vs
GENCOR INDUSTRIES INC（GENC）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
GENCOR INDUSTRIES INC的季度营收约是ROCKWELL MEDICAL, INC.的1.4倍（$23.6M vs $17.3M），GENCOR INDUSTRIES INC净利率更高（14.6% vs -9.2%，领先23.8%），ROCKWELL MEDICAL, INC.同比增速更快（-8.5% vs -25.0%），过去两年ROCKWELL MEDICAL, INC.的营收复合增速更高（-18.2% vs -23.9%）
Gencor Industries Inc是一家重型基建设备制造商，主打沥青生产装置、热力燃烧系统及配套道路施工机械，主要服务北美及全球建筑市场，客户涵盖公共基建项目方和私营建筑运营商。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
GENC vs RMTI — 直观对比
营收规模更大
GENC
是对方的1.4倍
$17.3M
营收增速更快
RMTI
高出16.5%
-25.0%
净利率更高
GENC
高出23.8%
-9.2%
两年增速更快
RMTI
近两年复合增速
-23.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $23.6M | $17.3M |
| 净利润 | $3.4M | $-1.6M |
| 毛利率 | 28.7% | 16.8% |
| 营业利润率 | 13.2% | — |
| 净利率 | 14.6% | -9.2% |
| 营收同比 | -25.0% | -8.5% |
| 净利润同比 | -9.8% | — |
| 每股收益（稀释后） | $0.23 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GENCRMTI
| Q1 26 | — | $17.3M | ||
| Q4 25 | $23.6M | $18.3M | ||
| Q3 25 | $18.8M | $15.9M | ||
| Q2 25 | $27.0M | $16.1M | ||
| Q1 25 | $38.2M | $18.9M | ||
| Q4 24 | $31.4M | $24.7M | ||
| Q3 24 | $20.9M | $28.3M | ||
| Q2 24 | $25.6M | $25.8M |
净利润GENCRMTI
| Q1 26 | — | $-1.6M | ||
| Q4 25 | $3.4M | $-554.0K | ||
| Q3 25 | $1.9M | $-1.8M | ||
| Q2 25 | $3.8M | $-1.5M | ||
| Q1 25 | $6.1M | $-1.5M | ||
| Q4 24 | $3.8M | $-756.0K | ||
| Q3 24 | $1.5M | $1.7M | ||
| Q2 24 | $2.6M | $343.0K |
毛利率GENCRMTI
| Q1 26 | — | 16.8% | ||
| Q4 25 | 28.7% | 21.1% | ||
| Q3 25 | 24.2% | 14.3% | ||
| Q2 25 | 26.5% | 15.6% | ||
| Q1 25 | 29.7% | 16.1% | ||
| Q4 24 | 27.6% | 14.7% | ||
| Q3 24 | 25.6% | 22.0% | ||
| Q2 24 | 23.9% | 17.6% |
营业利润率GENCRMTI
| Q1 26 | — | — | ||
| Q4 25 | 13.2% | -2.2% | ||
| Q3 25 | -1.2% | -9.9% | ||
| Q2 25 | 11.6% | -8.4% | ||
| Q1 25 | 17.0% | -7.2% | ||
| Q4 24 | 14.7% | -2.1% | ||
| Q3 24 | 5.9% | 6.8% | ||
| Q2 24 | 7.8% | 2.0% |
净利率GENCRMTI
| Q1 26 | — | -9.2% | ||
| Q4 25 | 14.6% | -3.0% | ||
| Q3 25 | 10.2% | -11.0% | ||
| Q2 25 | 14.2% | -9.3% | ||
| Q1 25 | 16.0% | -8.0% | ||
| Q4 24 | 12.1% | -3.1% | ||
| Q3 24 | 6.9% | 5.9% | ||
| Q2 24 | 10.0% | 1.3% |
每股收益（稀释后）GENCRMTI
| Q1 26 | — | $-0.04 | ||
| Q4 25 | $0.23 | $-0.01 | ||
| Q3 25 | $0.13 | $-0.05 | ||
| Q2 25 | $0.26 | $-0.05 | ||
| Q1 25 | $0.42 | $-0.04 | ||
| Q4 24 | $0.26 | $-0.02 | ||
| Q3 24 | $0.10 | $0.04 | ||
| Q2 24 | $0.17 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $147.7M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $215.2M | $35.9M |
| 总资产 | $228.9M | $57.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GENCRMTI
| Q1 26 | — | — | ||
| Q4 25 | $147.7M | $10.7M | ||
| Q3 25 | $136.3M | $13.6M | ||
| Q2 25 | $136.0M | $12.5M | ||
| Q1 25 | $143.7M | $11.4M | ||
| Q4 24 | $130.1M | $15.7M | ||
| Q3 24 | $115.4M | $12.3M | ||
| Q2 24 | $116.6M | $11.9M |
总债务GENCRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | — | — |
股东权益GENCRMTI
| Q1 26 | — | $35.9M | ||
| Q4 25 | $215.2M | $37.0M | ||
| Q3 25 | $211.8M | $37.0M | ||
| Q2 25 | $209.9M | $30.4M | ||
| Q1 25 | $206.1M | $31.5M | ||
| Q4 24 | $200.0M | $32.6M | ||
| Q3 24 | $196.1M | $29.1M | ||
| Q2 24 | $194.7M | $23.5M |
总资产GENCRMTI
| Q1 26 | — | $57.4M | ||
| Q4 25 | $228.9M | $57.1M | ||
| Q3 25 | $222.6M | $57.5M | ||
| Q2 25 | $220.2M | $52.6M | ||
| Q1 25 | $223.9M | $54.0M | ||
| Q4 24 | $218.2M | $59.2M | ||
| Q3 24 | $208.1M | $57.1M | ||
| Q2 24 | $201.8M | $53.0M |
负债/权益比GENCRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.1M | — |
| 自由现金流经营现金流 - 资本支出 | $10.1M | — |
| 自由现金流率自由现金流/营收 | 43.0% | — |
| 资本支出强度资本支出/营收 | 4.1% | — |
| 现金转化率经营现金流/净利润 | 3.23× | — |
| 过去12个月自由现金流最近4个季度 | $-3.2M | — |
8季度趋势，按日历期对齐
经营现金流GENCRMTI
| Q1 26 | — | — | ||
| Q4 25 | $11.1M | $2.3M | ||
| Q3 25 | $-275.0K | $-1.3M | ||
| Q2 25 | $-23.9M | $1.8M | ||
| Q1 25 | $12.4M | $-3.5M | ||
| Q4 24 | $14.8M | $865.0K | ||
| Q3 24 | $-3.2M | $4.3M | ||
| Q2 24 | $-1.0M | $1.4M |
自由现金流GENCRMTI
| Q1 26 | — | — | ||
| Q4 25 | $10.1M | $2.2M | ||
| Q3 25 | $-1.3M | $-1.5M | ||
| Q2 25 | $-24.4M | $1.7M | ||
| Q1 25 | $12.3M | $-3.5M | ||
| Q4 24 | $14.5M | $470.0K | ||
| Q3 24 | $-3.3M | $4.1M | ||
| Q2 24 | $-1.4M | $1.2M |
自由现金流率GENCRMTI
| Q1 26 | — | — | ||
| Q4 25 | 43.0% | 12.0% | ||
| Q3 25 | -6.8% | -9.6% | ||
| Q2 25 | -90.4% | 10.5% | ||
| Q1 25 | 32.2% | -18.8% | ||
| Q4 24 | 46.1% | 1.9% | ||
| Q3 24 | -15.8% | 14.4% | ||
| Q2 24 | -5.6% | 4.5% |
资本支出强度GENCRMTI
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 0.5% | ||
| Q3 25 | 5.4% | 1.4% | ||
| Q2 25 | 1.8% | 1.0% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 1.0% | 1.6% | ||
| Q3 24 | 0.4% | 0.7% | ||
| Q2 24 | 1.5% | 1.1% |
现金转化率GENCRMTI
| Q1 26 | — | — | ||
| Q4 25 | 3.23× | — | ||
| Q3 25 | -0.14× | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | 2.04× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | -2.22× | 2.57× | ||
| Q2 24 | -0.41× | 4.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
